Total body PET/CT (uExplorer)

DEVICE2 trials

Sponsors

Sun Yat-sen University, RenJi Hospital

Conditions

LymphomaNon-small Cell Lung Cancer

Unknown Phase

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

CompletedNCT04654234

Sun Yat-sen UniversityNon-small Cell Lung Cancer

Start: 2020-12-01End: 2023-12-30Updated: 2024-01-23

Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

RenJi HospitalLymphoma

Start: 2021-10-11End: 2024-07-20Target: 100Updated: 2021-10-15

Related Papers

Repeated dynamic [<sup>18</sup>F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067).

2024-07-026 citations

Dynamic 18F-FDG Total Body PET Imaging as a Predictive Marker of Induction Chemo-Immunotherapy Followed by Concurrent Chemoradiotherapy Response in Locally Advanced Non-Small Cell Lung Cancer.

2021-11-01

Dynamic 18F-FDG Total body PET Imaging as a predictive marker of induction chemo-immunotherapy response in locally advanced non-small cell lung cancer.

Journal of Clinical Oncology2021-05-201 citations

Assessing tumor metabolic heterogeneity of non-small cell lung cancer with total body PET-CT imaging on the uExplorer: Analysis of dynamic changes of 18F-FDG uptake.

Journal of Clinical Oncology2021-05-20